Indian J Pharm Close
 

Figure 4: The effect of Portulaca oleracea and its constituent alpha-linoleic acid on catalase concentration in (a) nonstimulated and (b) phytohemagglutinin-A-stimulated cultured human lymphocytes, in control group (C), dexamethasone (D), three concentrations of the extract (10, 40, and 160 μg/ml corresponding to P10, P40, and P160) and alpha-linoleic acid treated (5, 15, and 45 μg/ml corresponding to ALA5, ALA15, and ALA45) groups (for each group, n = 6). Data are presented as ± standard error of the mean *P < 0.05, ***P < 0.001 compared to Group C. ++P < 0.01, +++P < 0.001 compared to dexamethasone-treated group. Statistical analyses were performed using one-way analysis of variance with Tukey–Kramer post hoc test

Figure 4: The effect of <i>Portulaca oleracea</i> and its constituent alpha-linoleic acid on catalase concentration in (a) nonstimulated and (b) phytohemagglutinin-A-stimulated cultured human lymphocytes, in control group (C), dexamethasone (D), three concentrations of the extract (10, 40, and 160 μg/ml corresponding to P10, P40, and P160) and alpha-linoleic acid treated (5, 15, and 45 μg/ml corresponding to ALA5, ALA15, and ALA45) groups (for each group, <i>n</i> = 6). Data are presented as ± standard error of the mean *<i>P</i> < 0.05, ***<i>P</i> < 0.001 compared to Group C. <sup>++</sup><i>P</i> < 0.01, <sup>+++</sup><i>P</i> < 0.001 compared to dexamethasone-treated group. Statistical analyses were performed using one-way analysis of variance with Tukey–Kramer <i>post hoc</i> test